|
|
Build Your Online Product Catalogs?
| Product Name: |
Roflumilast 162401-32-3
|
| Supply Ability: |
|
| Related proudcts |
roflumilast, 162401-32-3, |
| Specifications |
99% |
| Price Term: |
|
| Port of loading: |
|
| Minimum Order |
|
| Unit Price: |
|
|
Product name:Roflumilast
Chemical name:3-(Cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide
CAS No.:162401-32-3
Specification:99.0%HPLC
Molecular Formula:C17H14Cl2F2N2O3
Molecular Weight:403.21
Appearance: white powder
Usage:On March 1,2011, the FDA approved the chronic obstructive pneumonia drug Daliresp (roflumilast), the drug used daily, can reduce asthma attack frequency or mitigate serious chronic obstructive pneumonia (COPD) symptoms.Roflumilast is a new category of COPD drug, phosphodiesterase - 4 (PDE - 4) inhibitors. Can be used among patients with serious COPD cough and bronchial symptom related much sputum, does not apply to mild emphysema.
|
| Company: |
Shanghai DND Pharm-Technology
|
| Contact: |
Mr. Arron Yu |
| Address: |
No.2-18A, Lane 85, Rongcheng Road,Pudong,Shanghai |
| Postcode: |
200120 |
| Tel: |
862158783620 |
| Fax: |
862158783595-8003 |
| E-mail: |
|
|
|
|
Home
